Stonnington Group’s Fulgent Genetics FLGT Stock Holding History

Stonnington Group’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$372K	Hold	11,850	–	–	0.1%	173
2022 Q4	$360K	Hold	11,850	–	–	0.1%	154
2022 Q3	$429K	Hold	11,850	–	–	0.12%	142
2022 Q2	$695K	Hold	11,850	–	–	0.19%	111
2022 Q1	$680K	Sell	11,850 -300	-2%	-$19.8K	0.16%	128
2021 Q4	$1.01M	Sell	12,150 -200	-2%	-$17.6K	0.22%	107
2021 Q3	$1.02M	Buy	12,350 +200	+2%	+$18.2K	0.23%	110
2021 Q2	$1.04M	Hold	12,150	–	–	0.23%	111
2021 Q1	$812K	Buy	+12,150	New	+$1.25M	0.2%	123

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stonnington Group's FLGT Position: Q1 2023 in Review

Stonnington Group held its Fulgent Genetics (FLGT) position steady in Q1 2023 at 11,850 shares worth $372K. The position accounts for 0.1% of the portfolio, ranked #173.

Stonnington Group first reported a position in FLGT in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.04M in Q2 2021. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

Stonnington Group held 11,850 shares of Fulgent Genetics worth $372K as of Q1 2023.
Stonnington Group left its Fulgent Genetics share count unchanged in Q1 2023.
Fulgent Genetics made up 0.1% of Stonnington Group's portfolio in Q1 2023, its #173 holding.
Stonnington Group first reported a position in Fulgent Genetics in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's Fulgent Genetics position peaked at $1.04M in Q2 2021.
215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.